Beaumont Financial Partners LLC Invests $388,000 in SPDR S&P Biotech ETF (XBI) Stock

Beaumont Financial Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 1st quarter, HoldingsChannel.com reports. The firm acquired 4,288 shares of the exchange traded fund’s stock, valued at approximately $388,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. JPMorgan Chase & Co. increased its position in SPDR S&P Biotech ETF by 98.7% in the third quarter. JPMorgan Chase & Co. now owns 3,265,715 shares of the exchange traded fund’s stock worth $313,084,000 after buying an additional 1,622,372 shares during the period. Bank of New York Mellon Corp increased its position in SPDR S&P Biotech ETF by 7.0% in the third quarter. Bank of New York Mellon Corp now owns 21,854 shares of the exchange traded fund’s stock worth $2,095,000 after buying an additional 1,435 shares during the period. Altfest L J & Co. Inc. increased its position in SPDR S&P Biotech ETF by 23.7% in the fourth quarter. Altfest L J & Co. Inc. now owns 25,410 shares of the exchange traded fund’s stock worth $1,823,000 after buying an additional 4,874 shares during the period. Perkins Coie Trust Co increased its position in SPDR S&P Biotech ETF by 0.4% in the fourth quarter. Perkins Coie Trust Co now owns 34,621 shares of the exchange traded fund’s stock worth $2,484,000 after buying an additional 136 shares during the period. Finally, RPG Investment Advisory LLC increased its position in SPDR S&P Biotech ETF by 0.7% in the fourth quarter. RPG Investment Advisory LLC now owns 20,406 shares of the exchange traded fund’s stock worth $1,464,000 after buying an additional 138 shares during the period.

Shares of NYSEARCA XBI opened at $81.77 on Wednesday. SPDR S&P Biotech ETF has a 1-year low of $64.38 and a 1-year high of $101.55.

ILLEGAL ACTIVITY NOTICE: “Beaumont Financial Partners LLC Invests $388,000 in SPDR S&P Biotech ETF (XBI) Stock” was published by WKRB News and is the property of of WKRB News. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark & copyright law. The correct version of this story can be read at https://www.wkrb13.com/2019/05/15/beaumont-financial-partners-llc-invests-388000-in-spdr-sp-biotech-etf-xbi-stock.html.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Story: Different Options Trading Strategies

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.